156 related articles for article (PubMed ID: 27062896)
1. Understanding the non-catalytic behavior of human butyrylcholinesterase silent variants: Comparison of wild-type enzyme, catalytically active Ala328Cys mutant, and silent Ala328Asp variant.
Lushchekina S; Nemukhin A; Varfolomeev S; Masson P
Chem Biol Interact; 2016 Nov; 259(Pt B):223-232. PubMed ID: 27062896
[TBL] [Abstract][Full Text] [Related]
2. Human butyrylcholinesterase polymorphism: Molecular modeling.
Lushchekina S; Delacour H; Lockridge O; Masson P
Int J Risk Saf Med; 2015; 27 Suppl 1():S80-1. PubMed ID: 26639724
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a novel BCHE "silent" allele: point mutation (p.Val204Asp) causes loss of activity and prolonged apnea with suxamethonium.
Delacour H; Lushchekina S; Mabboux I; Bousquet A; Ceppa F; Schopfer LM; Lockridge O; Masson P
PLoS One; 2014; 9(7):e101552. PubMed ID: 25054547
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a novel butyrylcholinesterase point mutation (p.Ala34Val), "silent" with mivacurium.
Delacour H; Lushchekina S; Mabboux I; Ceppa F; Masson P; Schopfer LM; Lockridge O
Biochem Pharmacol; 2014 Dec; 92(3):476-83. PubMed ID: 25264279
[TBL] [Abstract][Full Text] [Related]
5. An Indian butyrylcholinesterase variant L307P is not structurally stable: a molecular dynamics simulation study.
David SM; Venkatesan SK; Boopathy R
Chem Biol Interact; 2013 Mar; 203(1):30-5. PubMed ID: 23123771
[TBL] [Abstract][Full Text] [Related]
6. Computer-designed active human butyrylcholinesterase double mutant with a new catalytic triad.
Grigorenko BL; Novichkova DA; Lushchekina SV; Zueva IV; Schopfer LM; Nemukhin AV; Varfolomeev SD; Lockridge O; Masson P
Chem Biol Interact; 2019 Jun; 306():138-146. PubMed ID: 31009643
[TBL] [Abstract][Full Text] [Related]
7. Effects of viscosity and osmotic stress on the reaction of human butyrylcholinesterase with cresyl saligenin phosphate, a toxicant related to aerotoxic syndrome: kinetic and molecular dynamics studies.
Masson P; Lushchekina S; Schopfer LM; Lockridge O
Biochem J; 2013 Sep; 454(3):387-99. PubMed ID: 23782236
[TBL] [Abstract][Full Text] [Related]
8. Butyrylcholinesterase and G116H, G116S, G117H, G117N, E197Q and G117H/E197Q mutants: a molecular dynamics study.
Vyas S; Beck JM; Xia S; Zhang J; Hadad CM
Chem Biol Interact; 2010 Sep; 187(1-3):241-5. PubMed ID: 20399202
[TBL] [Abstract][Full Text] [Related]
9. Butyrylcholinesterase deficiency.
Delacour H; Dedome E; Courcelle S; Hary B; Ceppa F
Ann Biol Clin (Paris); 2016 Jun; 74(3):279-85. PubMed ID: 27237801
[TBL] [Abstract][Full Text] [Related]
10. Two novel mutations in the BCHE gene in patients with prolonged duration of action of mivacurium or succinylcholine during anaesthesia.
Gätke MR; Bundgaard JR; Viby-Mogensen J
Pharmacogenet Genomics; 2007 Nov; 17(11):995-9. PubMed ID: 18075469
[TBL] [Abstract][Full Text] [Related]
11. Design of high-activity mutants of human butyrylcholinesterase against (-)-cocaine: structural and energetic factors affecting the catalytic efficiency.
Zheng F; Yang W; Xue L; Hou S; Liu J; Zhan CG
Biochemistry; 2010 Oct; 49(42):9113-9. PubMed ID: 20886866
[TBL] [Abstract][Full Text] [Related]
12. Fundamental reaction mechanism for cocaine hydrolysis in human butyrylcholinesterase.
Zhan CG; Zheng F; Landry DW
J Am Chem Soc; 2003 Mar; 125(9):2462-74. PubMed ID: 12603134
[TBL] [Abstract][Full Text] [Related]
13. Molecular modeling evidence for His438 flip in the mechanism of butyrylcholinesterase hysteretic behavior.
Lushchekina SV; Nemukhin AV; Varfolomeev SD; Masson P
J Mol Neurosci; 2014 Mar; 52(3):434-45. PubMed ID: 24310732
[TBL] [Abstract][Full Text] [Related]
14. Molecular dynamics simulation of cocaine binding with human butyrylcholinesterase and its mutants.
Hamza A; Cho H; Tai HH; Zhan CG
J Phys Chem B; 2005 Mar; 109(10):4776-82. PubMed ID: 16851561
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a high-activity mutant of human butyrylcholinesterase against (-)-cocaine.
Yang W; Xue L; Fang L; Chen X; Zhan CG
Chem Biol Interact; 2010 Sep; 187(1-3):148-52. PubMed ID: 20060817
[TBL] [Abstract][Full Text] [Related]
16. Kinetic characterization of a cocaine hydrolase engineered from mouse butyrylcholinesterase.
Chen X; Huang X; Geng L; Xue L; Hou S; Zheng X; Brimijoin S; Zheng F; Zhan CG
Biochem J; 2015 Mar; 466(2):243-51. PubMed ID: 25486543
[TBL] [Abstract][Full Text] [Related]
17. Catalytic activities of a cocaine hydrolase engineered from human butyrylcholinesterase against (+)- and (-)-cocaine.
Xue L; Hou S; Yang W; Fang L; Zheng F; Zhan CG
Chem Biol Interact; 2013 Mar; 203(1):57-62. PubMed ID: 22917637
[TBL] [Abstract][Full Text] [Related]
18. Hydration change during the aging of phosphorylated human butyrylcholinesterase: importance of residues aspartate-70 and glutamate-197 in the water network as probed by hydrostatic and osmotic pressures.
Masson P; Cléry C; Guerra P; Redslob A; Albaret C; Fortier PL
Biochem J; 1999 Oct; 343 Pt 2(Pt 2):361-9. PubMed ID: 10510301
[TBL] [Abstract][Full Text] [Related]
19. Characterization of four BCHE mutations associated with prolonged effect of suxamethonium.
Brazzolotto X; Courcelle S; Sauvanet C; Guillon V; Igert A; Kononchik J; Nachon F; Ceppa F; Delacour H
Pharmacogenomics J; 2021 Apr; 21(2):165-173. PubMed ID: 33024248
[TBL] [Abstract][Full Text] [Related]
20. Computational redesign of human butyrylcholinesterase for anticocaine medication.
Pan Y; Gao D; Yang W; Cho H; Yang G; Tai HH; Zhan CG
Proc Natl Acad Sci U S A; 2005 Nov; 102(46):16656-61. PubMed ID: 16275916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]